Antitumor Efficacy of Lymphokine–activated Killer Cells and Recombinant Interleukin-2 in Vivo: Survival Benefit and Mechanisms of Tumor Escape in Mice Undergoing Lmmunotherapy

J. J. Mulé, S. E. Ettinghausen, P. J. Spiess, S. Shu, S. A. Rosenberg

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor Efficacy of Lymphokine–activated Killer Cells and Recombinant Interleukin-2 in Vivo: Survival Benefit and Mechanisms of Tumor Escape in Mice Undergoing Lmmunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences